GOLDMAN SACHS GROUP INC - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 43 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$153,000
+856.2%
359,982
+1376.1%
0.00%
Q4 2016$16,000
-81.2%
24,387
-10.1%
0.00%
Q3 2016$85,000
+39.3%
27,139
+38.6%
0.00%
Q2 2016$61,000
+1.7%
19,582
+18.9%
0.00%
Q1 2016$60,000
-97.5%
16,468
-96.9%
0.00%
Q4 2015$2,432,000
-9.6%
524,175
+18.7%
0.00%
Q3 2015$2,690,000
+287.6%
441,632
+448.2%
0.00%
Q2 2015$694,000
+601.0%
80,567
+263.7%
0.00%
Q1 2015$99,000
+65.0%
22,154
-41.7%
0.00%
Q4 2014$60,00037,9710.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,431,196$2,748,0001.18%
Abingworth LLP 437,994$832,0000.50%
Broadfin Capital, LLC 1,301,622$2,499,0000.26%
Rhenman & Partners Asset Management AB 400,000$768,0000.22%
BVF INC/IL 559,624$1,074,0000.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,691,857$3,248,0000.12%
Perceptive Advisors 478,456$919,0000.10%
Gruss Capital Management LP 1,720,000$3,302,0000.08%
SECTORAL ASSET MANAGEMENT INC 247,961$476,0000.02%
Spark Investment Management LLC 36,400$69,0000.01%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders